drug-resistant tuberculosis among hiv-infected patients starting antiretroviral therapy in durban, south africa耐药结核病感染艾滋病毒的患者开始抗逆转录病毒疗法在德班,南非.pdfVIP

Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa 1¤ 2 3 3 3 4 Jeffrey K. Hom , Bingxia Wang , Senica Chetty , Janet Giddy , Matilda Mazibuko , Jenny Allen , Rochelle P. Walensky1,2,5,6,9,11, Elena Losina1,2,6,7,10,11, Kenneth A. Freedberg1,2,6,8,11, Ingrid V. Bassett1,2,5,6,11* 1 Harvard Medical School, Boston, Massachusetts, United States of America, 2 Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, 3 McCord Hospital, Durban, South Africa, 4 University of KwaZulu-Natal Microbiology Laboratory and the Medical Research Council, Durban, South Africa, 5 Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America, 6 Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America, 7 Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America, 8 Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America, 9 Division of Infectious Disease, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, 10 Department of Orthopedics, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, 11 Harvard Center for AIDS Research (CFAR), Harvard University, Boston, Massachusetts, United States of America Abstract Objective: To estimate the prevalence of drug-resistant tuberculosis (TB) and describe the resistance patterns in patients commencing antiretroviral therapy (ART) in an HIV clinic in Durban, South Africa. Design: Cross-section